CQENS Technologies Inc.

2023 Q1 Form 10-Q Financial Statement

#000149315223016613 Filed on May 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $98.32K $2.586M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $102.1K
Receivables
Other Receivables
Total Short-Term Assets $200.4K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $172.7K
YoY Change
Goodwill
YoY Change
Intangibles $1.009M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.767M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $200.4K
Total Long-Term Assets $1.767M
Total Assets $1.967M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $130.4K
YoY Change
Accrued Expenses $184.7K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $822.3K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $822.3K
Total Long-Term Liabilities
Total Liabilities $878.5K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$20.74M
YoY Change
Common Stock $2.608K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.089M $3.768M
YoY Change
Total Liabilities & Shareholders Equity $1.967M
YoY Change

Cashflow Statement

Concept 2023 Q1 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
12799 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001479915
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2023Q1 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q1 CQENS Lessee Operating Lease Liability Payments Due After Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-55470
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CQENS Technologies Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1521407
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
5550 Nicollet Avenue
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55419
CY2023Q1 dei City Area Code
CityAreaCode
(612)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
812-2037
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26074595 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98321 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
219781 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
102101 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
182713 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
200422 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
402494 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
172685 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
177722 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1009147 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
973823 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
113436 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
126235 usd
CY2023Q1 CQENS Leasehold Improvements Net
LeaseholdImprovementsNet
13075 usd
CY2022Q4 CQENS Leasehold Improvements Net
LeaseholdImprovementsNet
14644 usd
CY2023Q1 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
458317 usd
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
458317 usd
CY2023Q1 us-gaap Assets
Assets
1967082 usd
CY2022Q4 us-gaap Assets
Assets
2153235 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
130365 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
222539 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
184736 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
94050 usd
CY2023Q1 CQENS Related Party Loan
RelatedPartyLoan
450000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57217 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52217 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
822318 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
368806 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56219 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74018 usd
CY2023Q1 us-gaap Liabilities
Liabilities
878537 usd
CY2022Q4 us-gaap Liabilities
Liabilities
442824 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26074595 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26074595 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26065595 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26065595 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2608 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2607 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21825940 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21261500 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20740003 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19553696 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1088545 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1710411 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1967082 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2153235 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
684523 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
413953 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
337072 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
154928 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
161351 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
232047 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1182946 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
800928 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1182946 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-800928 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3361 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1186307 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-800928 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26069645 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26015595 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1710411 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
384441 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
180000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1186307 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1088545 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4430586 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
138446 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-800928 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3768104 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1186307 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-800928 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
23729 usd
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
16245 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
20476 usd
CY2023Q1 us-gaap Depreciation
Depreciation
5037 usd
CY2022Q1 us-gaap Depreciation
Depreciation
4972 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
384441 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
138446 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-80612 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
324681 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-92174 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
99808 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-12799 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
90686 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-51005 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-693976 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-917143 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
57484 usd
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
77758 usd
CY2022Q1 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
7800 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57484 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-85558 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
180000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
450000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
630000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-121460 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1002701 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
219781 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3588377 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
98321 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2585676 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
122476 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12504 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
113436 usd
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
7500 shares
CY2023Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
150000 usd
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1500 shares
CY2023Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
30000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
384441 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
138446 usd
CY2022Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
0 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26074595 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26074595 shares
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57217 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
59324 usd
CY2023Q1 CQENS Leasehold Improvements Net
LeaseholdImprovementsNet
13075 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
113436 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57217 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56219 usd
CY2023Q1 CQENS Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
12799 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y29D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0525 pure
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
42676 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56219 usd
CY2022 us-gaap Manufacturing Costs
ManufacturingCosts
458317 usd
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
458317 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001493152-23-016613-index-headers.html Edgar Link pending
0001493152-23-016613-index.html Edgar Link pending
0001493152-23-016613.txt Edgar Link pending
0001493152-23-016613-xbrl.zip Edgar Link pending
cqens-20230331.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cqens-20230331_cal.xml Edgar Link unprocessable
cqens-20230331_def.xml Edgar Link unprocessable
cqens-20230331_lab.xml Edgar Link unprocessable
cqens-20230331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed